Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Share-based Compensation (2020 - 2025)

Agilon Health (AGL) has disclosed Share-based Compensation for 6 consecutive years, with $9.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 317.18% year-over-year to $9.5 million, compared with a TTM value of $49.1 million through Dec 2025, down 3.04%, and an annual FY2025 reading of $49.1 million, down 3.04% over the prior year.
  • Share-based Compensation was $9.5 million for Q4 2025 at Agilon Health, up from $7.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $273.4 million in Q2 2021 and bottomed at $1.5 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $24.4 million, with a median of $12.6 million recorded in 2021.
  • The sharpest move saw Share-based Compensation soared 12155.49% in 2021, then crashed 97.6% in 2022.
  • Year by year, Share-based Compensation stood at $4.4 million in 2021, then skyrocketed by 125.44% to $10.0 million in 2022, then soared by 55.91% to $15.5 million in 2023, then tumbled by 85.29% to $2.3 million in 2024, then soared by 317.18% to $9.5 million in 2025.
  • Business Quant data shows Share-based Compensation for AGL at $9.5 million in Q4 2025, $7.5 million in Q3 2025, and $15.4 million in Q2 2025.